Literature DB >> 18980253

Accelerator mass spectrometry of small biological samples.

Mehran Salehpour1, Niklas Forsgard, Göran Possnert.   

Abstract

Accelerator mass spectrometry (AMS) is an ultra-sensitive technique for isotopic ratio measurements. In the biomedical field, AMS can be used to measure femtomolar concentrations of labeled drugs in body fluids, with direct applications in early drug development such as Microdosing. Likewise, the regenerative properties of cells which are of fundamental significance in stem-cell research can be determined with an accuracy of a few years by AMS analysis of human DNA. However, AMS nominally requires about 1 mg of carbon per sample which is not always available when dealing with specific body substances such as localized, organ-specific DNA samples. Consequently, it is of analytical interest to develop methods for the routine analysis of small samples in the range of a few tens of microg. We have used a 5 MV Pelletron tandem accelerator to study small biological samples using AMS. Different methods are presented and compared. A (12)C-carrier sample preparation method is described which is potentially more sensitive and less susceptible to contamination than the standard procedures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980253     DOI: 10.1002/rcm.3808

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  4 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

2.  Directly coupled high-performance liquid chromatography-accelerator mass spectrometry measurement of chemically modified protein and peptides.

Authors:  Avi T Thomas; Benjamin J Stewart; Ted J Ognibene; Kenneth W Turteltaub; Graham Bench
Journal:  Anal Chem       Date:  2013-03-20       Impact factor: 6.986

3.  Carotid plaque age is a feature of plaque stability inversely related to levels of plasma insulin.

Authors:  Sara Hägg; Mehran Salehpour; Peri Noori; Jesper Lundström; Göran Possnert; Rabbe Takolander; Peter Konrad; Stefan Rosfors; Arno Ruusalepp; Josefin Skogsberg; Jesper Tegnér; Johan Björkegren
Journal:  PLoS One       Date:  2011-04-07       Impact factor: 3.240

4.  Absorption, metabolism and excretion of opicapone in human healthy volunteers.

Authors:  Ana I Loureiro; Francisco Rocha; Ana T Santos; Nand Singh; Maria João Bonifácio; Rui Pinto; Laszlo E Kiss; Patrício Soares-da-Silva
Journal:  Br J Clin Pharmacol       Date:  2022-05-20       Impact factor: 3.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.